139755-80-9|Iobenguane|2-[(3-iodophenyl)methyl]guanidine|-范德生物科技公司

Iobenguane

NMR下载 COA and HPLC MSDS下载
names：
2-[(3-iodophenyl)methyl]guanidine
CAS号：
139755-80-9
MDL Number：
MF(分子式)： C8H10IN3 MW(分子量)： 275.0896
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Iobenguane
英文别名	Iobenguane, Adreview, Metaiodobenzylguanidine
CAS号	139755-80-9
Inchi	InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)
InchiKey	PDWUPXJEEYOOTR-UHFFFAOYSA-N
分子式 Formula	C8H10IN3
分子量 Molecular Weight	275.0896
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Iobenguane(CAS:139755-80-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Iobenguane is a radiopharmaceutical, used in a scintigraphy method called MIBG scan. Iobenguane is a radiolabeled molecule similar to noradrenaline. It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as phaeochromocytomas and neuroblastomas. With I-131 it can also be used to eradicate tumor cells that take up and metabolize norepinephrine.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Feola M, Chauvie S, Biggi A, Testa M. Role of (123)I-Iobenguane Myocardial Scintigraphy in Predicting Short-term Left Ventricular Functional Recovery: An Interesting Image. J Clin Imaging Sci. 2015 Oct 30;

5:56. doi: 10.4103/2156-7514.168707. eCollection 2015. PubMed PMID: 26664773; PubMed Central PMCID: PMC4647125.

[3]Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW. Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane. J Nucl Med. 2014 May;55(5):765-71. doi: 10.2967/jnumed.113.124057. Epub 2014 Mar 13. PubMed PMID: 24627436.

[4]Coleman RE, Stubbs JB, Barrett JA, de la Guardia M, Lafrance N, Babich JW. Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid. Cancer Biother Radiopharm. 2009 Aug;24(4):469-75. doi: 10.1089/cbr.2008.0584. PubMed PMID: 19694582.

[5] Cortés-Blanco A, Martínez Lázaro R, Vargas Castrillón E. [Authorized specifications for human use in clinical practice of radiopharmaceuticals composed of iobenguane (123I) marketed in Spain]. Rev Esp Med Nucl. 2008 Nov-Dec;27(6):468-74. Spanish. PubMed PMID: 19094909.

5: Hinkle GH, Dura JV, Morosco RS, Nahata MC. Extended stability of iobenguane under simulated clinical conditions. Am J Health Syst Pharm. 2008 Jan 15;65(2):142-4. doi: 10.2146/ajhp070247. PubMed PMID: 18192259.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开